China Red Eye Study on Allergic Conjunctivitis
NCT03812952 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2019-01-23
Summary
This study is the first multi-center cross-sectional study on the diagnosis and misdiagnosis of allergic conjunctivitis in the ophthalmology clinic in China. It provides a clinical basis for the standardized diagnosis and treatment of allergic eye diseases.
Conditions
- Allergic Conjunctivitis
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Principal Investigators
-
Xiaofeng Lin · Zhongshan Ophthalmic Center, Sun Yat-sen University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-01
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- China
Study Locations
More Related Trials
-
Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes
NCT01679015 ·Status: COMPLETED
-
Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis
NCT00432757 ·Status: COMPLETED ·Phase: PHASE3
-
Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) Patients
NCT02712762 ·Status: COMPLETED
-
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
NCT03557203 ·Status: UNKNOWN
-
Non-Pharmaceutical Treatment of Seasonal Allergic Conjunctivitis
NCT01569191 ·Status: COMPLETED ·Phase: PHASE4
-
Sea Water in Allergic Conjunctivitis
NCT04695795 ·Status: UNKNOWN
-
Evaluation of Efficacy of Ophthalmic Solution in Seasonal Allergic Conjunctivitis
NCT00364091 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Efficacy of Ophthalmic Solution in Induced Acute Allergic Conjunctivitis
NCT00241319 ·Status: COMPLETED ·Phase: PHASE3
-
Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis
NCT00133627 ·Status: COMPLETED ·Phase: PHASE4
-
Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy
NCT07171307 ·Status: NOT_YET_RECRUITING
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
NCT05591755 ·Status: COMPLETED ·Phase: PHASE3
-
Systemic Pharmacokinetics of BOL-303224-A
NCT00407589 ·Status: COMPLETED ·Phase: PHASE1
-
Dry Eye Evaluation System Based on Bioinformatics
NCT04109170 ·Status: UNKNOWN
-
A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis
NCT00921895 ·Status: COMPLETED ·Phase: NA
-
Acupuncture for Dry Eye Syndrome
NCT00969280 ·Status: COMPLETED ·Phase: PHASE3
-
Dry Eye Under China's Dynamic COVID-zero Strategy
NCT05476068 ·Status: COMPLETED
-
Phase 1 Study for Safety and Tolerability of IL-1-Ra Topically Administered to Eyes of Healthy Adult Subjects
NCT03383276 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
NCT05579730 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Short-term and Long Term Efficacy of Acupuncture in Ocular and Oral Dryness Symptoms of Dry Eye Syndrome
NCT04877483 ·Status: UNKNOWN ·Phase: NA
-
Evaluation and Treatment of Patients With Corneal and External Diseases
NCT00008541 ·Status: COMPLETED
-
Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis
NCT00244543 ·Status: COMPLETED ·Phase: PHASE3
-
AL-38583 Ophthalmic Solution for Allergic Conjunctivitis Associated Inflammation
NCT01001091 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Clinical and Microbial Efficacy and Safety of AzaSite Compared to Tobramycin for Bacterial Conjunctivitis (C-01-401-004)
NCT00105469 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease
NCT00809003 ·Status: COMPLETED
-
Acupuncture for Dry Eye
NCT01105221 ·Status: COMPLETED ·Phase: PHASE3